Bessemer Group Inc. Takes $31,000 Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Bessemer Group Inc. bought a new position in Utah Medical Products, Inc. (NASDAQ:UTMD) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 500 shares of the medical instruments supplier’s stock, valued at approximately $31,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets raised its holdings in shares of Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after purchasing an additional 566 shares during the period. State Street Corp grew its stake in Utah Medical Products by 0.9% during the third quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock worth $5,434,000 after buying an additional 694 shares during the period. Barclays PLC increased its position in shares of Utah Medical Products by 214.1% in the third quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock worth $306,000 after acquiring an additional 3,118 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Utah Medical Products by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier’s stock valued at $6,497,000 after acquiring an additional 8,516 shares during the period. Finally, Virtu Financial LLC acquired a new position in shares of Utah Medical Products during the 3rd quarter valued at $207,000. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Price Performance

NASDAQ:UTMD opened at $52.30 on Friday. The business’s 50-day moving average is $57.18 and its two-hundred day moving average is $61.38. The firm has a market capitalization of $171.65 million, a PE ratio of 13.24 and a beta of 0.17. Utah Medical Products, Inc. has a 12 month low of $52.27 and a 12 month high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, April 3rd. Investors of record on Friday, March 14th were paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 2.33%. The ex-dividend date was Friday, March 14th. Utah Medical Products’s dividend payout ratio (DPR) is 30.89%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.